
Sign up to save your podcasts
Or
An HRS meeting recap, Impella failure, sacubitril/valsartan, the purpose of trials, and a major breakthrough in evidence generation are the topics discussed by John Mandrola, MD in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit: https://www.medscape.com/twic
I. HRS Meeting Recap
II. Impella in VT ablation
- First-in-human Experience with Impella 5.0/5.5 for High-Risk Patients with Advanced Heart Failure Undergoing VT Ablationhttps://www.jacc.org/doi/10.1016/j.jacc.2023.05.012
III. Sacubitril/Valsartan
ARNI Bests ARB to Reduce NT-proBNP in Stabilized Preserved-EF HF
https://www.medscape.com/viewarticle/992461
- Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure
https://www.jacc.org/doi/10.1016/j.jacc.2023.04.019
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
https://www.nejm.org/doi/full/10.1056/nejmoa1908655
- Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF
https://doi.org/10.1093/eurheartj/ehad344
- Bogdan Tweet
https://twitter.com/bogdienache/status/1660356776204595201?s=20
IV. Big Change in Reporting of Medical Evidence – Elan Trial
- Early versus Later Anticoagulation for Stroke with Atrial Fibrillationhttps://www.nejm.org/doi/full/10.1056/NEJMoa2303048
- Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trial https://doi.org/10.1177/23969873221106043
You may also like:
Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine
https://www.medscape.com/features/public/machine
The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.
https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact: [email protected]
4.9
826826 ratings
An HRS meeting recap, Impella failure, sacubitril/valsartan, the purpose of trials, and a major breakthrough in evidence generation are the topics discussed by John Mandrola, MD in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit: https://www.medscape.com/twic
I. HRS Meeting Recap
II. Impella in VT ablation
- First-in-human Experience with Impella 5.0/5.5 for High-Risk Patients with Advanced Heart Failure Undergoing VT Ablationhttps://www.jacc.org/doi/10.1016/j.jacc.2023.05.012
III. Sacubitril/Valsartan
ARNI Bests ARB to Reduce NT-proBNP in Stabilized Preserved-EF HF
https://www.medscape.com/viewarticle/992461
- Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure
https://www.jacc.org/doi/10.1016/j.jacc.2023.04.019
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
https://www.nejm.org/doi/full/10.1056/nejmoa1908655
- Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF
https://doi.org/10.1093/eurheartj/ehad344
- Bogdan Tweet
https://twitter.com/bogdienache/status/1660356776204595201?s=20
IV. Big Change in Reporting of Medical Evidence – Elan Trial
- Early versus Later Anticoagulation for Stroke with Atrial Fibrillationhttps://www.nejm.org/doi/full/10.1056/NEJMoa2303048
- Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trial https://doi.org/10.1177/23969873221106043
You may also like:
Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine
https://www.medscape.com/features/public/machine
The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.
https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact: [email protected]
132 Listeners
13 Listeners
322 Listeners
160 Listeners
496 Listeners
18 Listeners
272 Listeners
3,321 Listeners
87 Listeners
135 Listeners
1,081 Listeners
60 Listeners
186 Listeners
514 Listeners
321 Listeners
59 Listeners
25 Listeners
8 Listeners
424 Listeners
363 Listeners